MedPath

ZANAFLEX

Approved
Approval ID

939d9fec-727e-488e-adc4-cc941292b23e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 25, 2011

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TIZANIDINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-871
Application NumberNDA021447
Product Classification
M
Marketing Category
C73594
G
Generic Name
TIZANIDINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateApril 25, 2011
FDA Product Classification

INGREDIENTS (5)

HYDROXYMETHYL CELLULOSEInactive
Code: 273FM27VK1
Classification: IACT
TIZANIDINE HYDROCHLORIDEActive
Quantity: 4 mg in 1 1
Code: B53E3NMY5C
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

TIZANIDINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-756
Application NumberNDA021447
Product Classification
M
Marketing Category
C73594
G
Generic Name
TIZANIDINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateApril 25, 2011
FDA Product Classification

INGREDIENTS (5)

TIZANIDINE HYDROCHLORIDEActive
Quantity: 6 mg in 1 1
Code: B53E3NMY5C
Classification: ACTIB
HYDROXYMETHYL CELLULOSEInactive
Code: 273FM27VK1
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZANAFLEX - FDA Drug Approval Details